By Simon Pitman, 15-Jun-2016
The new model has been proposed by Marine Norlunc, biology project manager at Syntivia, and was unveiled at the centre Pierre Poitier in Toulouse earlier this summer.
The model is being positioned as an alternative for preclinical toxicological testing methods, and answers to EU laws that are completely phasing out the testing of all cosmetic ingredients on animals.
The team at Syntivia says that its 3D skin model was developed in answer to the problems that the only OECD approved alternative to animal testing is a reconstructed epidermis.
The development team set about the project with the aim of giving cosmetic companies more effective and easier to use choices, and teamed up with ITAV Institute for Advanced Life Science and Toulouse Tech Transfer to get the project off the ground.
According to the team, the project resulted in the creation and validation of a new and completely characterized epidermis
model that is perfectly functional for in-vitro studies.
Welcome to this 33rd edition of ZOOM, a magazine dedicated to preclinical trials and clinical…
Precision and reliability are essential in dermatology and aesthetics. The Antera 3D CS by Miravex…
PhD Trials, one of the leading CROs for performing in vivo studies with cosmetic products…